{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T19:11:58Z","timestamp":1781118718708,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,11,24]],"date-time":"2008-11-24T00:00:00Z","timestamp":1227484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00392-008-0741-y","type":"journal-article","created":{"date-parts":[[2008,11,24]],"date-time":"2008-11-24T06:52:59Z","timestamp":1227509579000},"page":"208-212","source":"Crossref","is-referenced-by-count":62,"title":["Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors"],"prefix":"10.1007","volume":"98","author":[{"given":"Konstantinos P.","family":"Letsas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalis","family":"Efremidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros P.","family":"Kounas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loukas K.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Gavrielatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis P.","family":"Alexanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos P.","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos S.","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotis","family":"Kardaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,24]]},"reference":[{"key":"741_CR1","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/01.CIR.83.6.1888","volume":"83","author":"A Algra","year":"1991","unstructured":"Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J (1991) QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 83:1888\u20131894","journal-title":"Circulation"},{"key":"741_CR2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0002-9149(02)02337-8","volume":"89","author":"MM Bednar","year":"2002","unstructured":"Bednar MM, Harrigan EP, Ruskin JN (2002) Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc. Am J Cardiol 89:1316\u20131319","journal-title":"Am J Cardiol"},{"key":"741_CR3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00392-006-0420-9","volume":"95","author":"B Chatterjee","year":"2006","unstructured":"Chatterjee B, Burgi U (2006) Syncope of a drug addict \u2013 a special case. Clin Res Cardiol 95:557\u2013559","journal-title":"Clin Res Cardiol"},{"key":"741_CR4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2165\/00002018-200124080-00002","volume":"24","author":"MD Drici","year":"2001","unstructured":"Drici MD, Clement N (2001) Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf 24:575\u2013585","journal-title":"Drug Saf"},{"key":"741_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2003.04.055","volume":"96","author":"RM Gowda","year":"2004","unstructured":"Gowda RM, Khan IA, Wilbur SL, Vasavada BC, Sacchi TJ (2004) Torsade de pointes: the clinical considerations. Int J Cardiol 96:1\u20136","journal-title":"Int J Cardiol"},{"key":"741_CR6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.hrthm.2005.07.017","volume":"2","author":"EK Heist","year":"2005","unstructured":"Heist EK, Ruskin JN (2005) Drug-induced proarrhythmia and use of QTc-prolonging agents: clues for clinicians. Heart Rhythm 2:S1\u2013S8","journal-title":"Heart Rhythm"},{"key":"741_CR7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00392-004-0129-6","volume":"93","author":"S Kaab","year":"2004","unstructured":"Kaab S, Pfeufer A, Hinterseer M, Nabauer M, Schulze-Bahr E (2004) Long QT syndrome. Why does sex matter? Z Kardiol 93:641\u2013645","journal-title":"Z Kardiol"},{"key":"741_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/HCO.0b013e32801129eb","volume":"22","author":"PJ Kannankeril","year":"2007","unstructured":"Kannankeril PJ, Roden DM (2007) Drug-induced long QT and torsade de pointes: recent advances. Curr Opin Cardiol 22:39\u201343","journal-title":"Curr Opin Cardiol"},{"key":"741_CR9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0002-9343(01)01011-7","volume":"112","author":"IA Khan","year":"2002","unstructured":"Khan IA (2002) Clinical and therapeutic aspects of congenital and acquired long QT syndrome. Am J Med 112:58\u201366","journal-title":"Am J Med"},{"key":"741_CR10","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1161\/01.CIR.94.10.2535","volume":"94","author":"MH Lehmann","year":"1996","unstructured":"Lehmann MH, Hardy S, Archibald D, Quart B, MacNeil DJ (1996) Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation 94:2535\u20132541","journal-title":"Circulation"},{"key":"741_CR11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijcard.2005.07.055","volume":"112","author":"KP Letsas","year":"2006","unstructured":"Letsas KP, Alexanian IP, Pappas LK, Kounas SP, Efremidis M, Sideris A, Kardaras F (2006) QT interval prolongation and torsade de pointes associated with indapamide. Int J Cardiol 112:373\u2013374","journal-title":"Int J Cardiol"},{"key":"741_CR12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2125.2000.00134.x","volume":"49","author":"K Ohyama","year":"2000","unstructured":"Ohyama K, Nakajima M, Suzuki M, Shimada N, Yamazaki H, Yokoi T (2000) Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions. Br J Clin Pharmacol 49:244\u2013253","journal-title":"Br J Clin Pharmacol"},{"key":"741_CR13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/01.RES.0000161077.53751.e6","volume":"96","author":"A Pfeufer","year":"2005","unstructured":"Pfeufer A, Jalilzadeh S, Perz S, Mueller JC, Hinterseer M, Illig T, Akyol M, Huth C, Schopfer-Wendels A, Kuch B, Steinbeck G, Holle R, Nabauer M, Wichmann HE, Meitinger T, Kaab S (2005) Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ Res 96:693\u2013701","journal-title":"Circ Res"},{"key":"741_CR14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1015793113771","volume":"16","author":"SG Priori","year":"2002","unstructured":"Priori SG, Napolitano C (2002) Genetic defects of cardiac ion channels. The hidden substrate for torsades de pointes. Cardiovasc Drugs Ther 16:89\u201392","journal-title":"Cardiovasc Drugs Ther"},{"key":"741_CR15","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMoa022147","volume":"348","author":"SG Priori","year":"2003","unstructured":"Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348:1866\u20131874","journal-title":"N Engl J Med"},{"key":"741_CR16","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","volume":"350","author":"DM Roden","year":"2004","unstructured":"Roden DM (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350:1013\u20131022","journal-title":"N Engl J Med"},{"key":"741_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0014-5793(98)01444-6","volume":"440","author":"B Rosati","year":"1998","unstructured":"Rosati B, Rocchetti M, Zaza A, Wanke E (1998) Sulfonylureas blockade of neural and cardiac HERG channels. FEBS Lett 440:125\u2013130.","journal-title":"FEBS Lett"},{"key":"741_CR18","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/eurheartj\/ehi312","volume":"26","author":"SM Straus","year":"2005","unstructured":"Straus SM, Sturkenboom MC, Bleumink GS, Dieleman JP, van der Lei J, de Graeff PA, Kingma JH, Stricker BH (2005) Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J 26:2007\u20132012","journal-title":"Eur Heart J"},{"key":"741_CR19","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/hc4701.099579","volume":"104","author":"JM Opstal van","year":"2001","unstructured":"van Opstal JM, Schoenmakers M, Verduyn SC, de Groot SH, Leunissen JD, van Der Hulst FF, Molenschot MM, Wellens HJ, Vos MA (2001) Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Circulation 104:2722\u20132727","journal-title":"Circulation"},{"key":"741_CR20","first-page":"17095614","volume":"PMID","author":"Wang","year":"2006","unstructured":"Wang L, Wible BA, Wan X, Ficker E (2006) Cardiac glycosides as novel inhibitors of HERG channel trafficking. J Pharmacol Exp Ther PMID: 17095614","journal-title":"J Pharmacol Exp Ther"},{"key":"741_CR21","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","volume":"89","author":"YG Yap","year":"2003","unstructured":"Yap YG, Camm AJ (2003) Drug induced QT prolongation and torsades de pointes. Heart 89:1363\u20131372","journal-title":"Heart"},{"key":"741_CR22","first-page":"282","volume":"82","author":"D Zeltser","year":"2003","unstructured":"Zeltser D, Justo D, Halkin A, Prokhorov V, Heller K, Viskin S (2003) Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) 82:282\u2013290","journal-title":"Medicine (Baltimore)"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-008-0741-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-008-0741-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-008-0741-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:21:55Z","timestamp":1559060515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-008-0741-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,24]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1007\/s00392-008-0741-y","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,24]]}}}